Significance of adrenomedullin and the role of adrecizumab in sepsis
Main Author: | Abhijit Nair |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Saudi Journal of Anaesthesia |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2021;volume=15;issue=2;spage=228;epage=229;aulast=Nair |
Similar Items
-
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
by: Christopher Geven, et al.
Published: (2018-06-01) -
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab
by: Mahir Karakas, et al.
Published: (2020-08-01) -
Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
by: Alice Blet, et al.
Published: (2019-05-01) -
Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
by: Christopher Geven, et al.
Published: (2018-02-01) -
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
by: Alexandre Mebazaa, et al.
Published: (2018-12-01)